https://scholars.lib.ntu.edu.tw/handle/123456789/568553
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | HONG-YUAN HSU | en_US |
dc.contributor.author | MEI-HWEI CHANG | en_US |
dc.contributor.author | YEN-HSUAN NI | en_US |
dc.contributor.author | Chiang C.-L. | en_US |
dc.contributor.author | HUEY-LING CHEN | en_US |
dc.contributor.author | JIA-FENG WU | en_US |
dc.contributor.author | PEI-JER CHEN | en_US |
dc.date.accessioned | 2021-07-03T03:34:43Z | - |
dc.date.available | 2021-07-03T03:34:43Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0022-1899 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984550744&doi=10.1086%2f651378&partnerID=40&md5=c9b02c5e91c56765af65b2e34b6cf1e3 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/568553 | - |
dc.description.abstract | Background. Mutants of the a determinant of hepatitis B surface antigen (HBsAg) can escape neutralization by vaccine-induced antibodies and prevail in an immunized population. Methods. We evaluated the a mutants in a pediatric population surveyed in 2004 and compared these findings with the data of previous surveys. Results. There were 38 children and 74 adolescents who were HBsAg positive, and serum hepatitis B virus (HBV) DNA was obtained and tested from 31 and 34 of them, respectively. The a mutants were found in 7 (22.6%) of 31 HBV DNA-positive children and in 7 (0.10%) of 7234 children, the entire population that was surveyed in 2004. After the beginning of universal immunization, the very low prevalence of mutants has remained unchanged for 20 years. More a mutants were found in immunized than in nonimmunized HBV DNA-positive children aged 1-4 years old (31% vs 4%, P = .016) but not in those children aged 5-12 years old. Approximately 68% of immunized, mutant-infected children had carrier mothers. More a mutants emerged in children immunized with plasma-derived vaccines than in those immunized with recombinant vaccines (14 of 5166 vs 3 of 4970, respectively; P = .04). HBV DNA levels were significantly lower in hepatitis B e antigen-positive sera containing the G145R mutant than were levels in sera containing wild-type virus. HBsAg-negative sera containing a mutants had very low HBV DNA levels. Conclusions. Less infectivity of G145R, recombinant vaccine use, and mutant loss with older age seem to decrease the a mutant prevalence in an immunized population over time. ? 2010 by the Infectious Diseases Society of America. All rights reserved. | - |
dc.publisher | Oxford University Press | - |
dc.relation.ispartof | Journal of Infectious Diseases | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | hepatitis B surface antigen; recombinant vaccine; virus DNA; adolescent; age distribution; article; child; cohort analysis; controlled study; genotype; health survey; Hepatitis B virus; human; immunization; infant; major clinical study; newborn; pediatrics; preschool child; prevalence; priority journal; school child; wild type | - |
dc.title | No increase in prevalence of hepatitis B Surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1086/651378 | - |
dc.identifier.scopus | 2-s2.0-84984550744 | - |
dc.relation.pages | 1192-1200 | - |
dc.relation.journalvolume | 201 | - |
dc.relation.journalissue | 8 | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Medical Education and Bioethics | - |
crisitem.author.dept | Pediatrics-NTUH | - |
crisitem.author.dept | Pediatrics-NTUH | - |
crisitem.author.dept | Pediatrics | - |
crisitem.author.dept | Pediatrics | - |
crisitem.author.dept | Pediatrics-NTUH | - |
crisitem.author.dept | Medical Education and Bioethics | - |
crisitem.author.dept | Pediatrics-NTUH | - |
crisitem.author.dept | Pediatrics | - |
crisitem.author.dept | Pediatrics | - |
crisitem.author.dept | Pediatrics-NTUH | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.orcid | 0000-0002-5720-4835 | - |
crisitem.author.orcid | 0000-0002-3648-9261 | - |
crisitem.author.orcid | 0000-0002-1158-5249 | - |
crisitem.author.orcid | 0000-0002-4074-5838 | - |
crisitem.author.orcid | 0000-0001-6343-1658 | - |
crisitem.author.orcid | 0000-0001-8316-3785 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。